This Citigroup Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
This Citigroup Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
這位花旗集團分析師轉爲看好;以下是週二的5個頂級升級推薦
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
華爾街頂級分析師改變了對這些知名人士的看法。要全面了解所有分析師評級變動,包括上調和降級,請參閱我們的分析師評級頁面。
- Keefe, Bruyette & Woods analyst David Konrad upgraded the rating for Citigroup Inc. (NYSE:C) from Market Perform to Outperform and raised the price target from $70 to $82. Citigroup shares closed at $71.39 on Monday. See how other analysts view this stock.
- B of A Securities analyst Vivek Arya upgraded Credo Technology Group Holding Ltd (NASDAQ:CRDO) from Underperform to Buy and boosted the price target from $27 to $80. Credo Technology shares closed at $47.80 on Monday. See how other analysts view this stock.
- Jefferies analyst Rob Dickerson upgraded the rating for The Kroger Co. (NYSE:KR) from Hold to Buy and increased the price target from $54 to $73. Kroger shares closed at $60.15 on Monday. See how other analysts view this stock.
- Wells Fargo analyst Donald Fandetti upgraded Synchrony Financial (NYSE:SYF) from Equal-Weight to Overweight and boosted the price target from $60 to $85. Synchrony Finl shares closed at $67.09 on Monday. See how other analysts view this stock.
- Deutsche Bank analyst George Hill upgraded the rating for CVS Health Corporation (NYSE:CVS) from Hold to Buy and maintained the price target of $66. CVS Health shares closed at $59.08 on Monday. See how other analysts view this stock.
- Keefe、Bruyette & Woods分析師戴維·康拉德將花旗集團(紐約證券交易所代碼:C)的評級從市場表現上調至跑贏大盤,並將目標股價從70美元上調至82美元。花旗集團股價週一收於71.39美元。看看其他分析師如何看待這隻股票。
- b of A 證券分析師維維克·艾莉亞將信達科技集團控股有限公司(納斯達克股票代碼:CRDO)從 「表現不佳」 上調至 「買入」,並將目標股價從27美元上調至80美元。Credo Technology股價週一收於47.80美元。看看其他分析師如何看待這隻股票。
- 傑富瑞分析師羅布·迪克森上調了克羅格公司的評級。紐約證券交易所代碼:KR)從 「持有」 改爲 「買入」,並將目標股價從54美元上調至73美元。克羅格股價週一收於60.15美元。看看其他分析師如何看待這隻股票。
- 富國銀行分析師唐納德·範德蒂將Synchrony Financial(紐約證券交易所代碼:SYF)從等重上調至增持,並將目標股價從60美元上調至85美元。Synchrony Finl股價週一收於67.09美元。看看其他分析師如何看待這隻股票。
- 德意志銀行分析師喬治·希爾將CVS Health Corporation(紐約證券交易所代碼:CVS)的評級從持有上調至買入,並維持66美元的目標股價。週一,CVS Health股價收於59.08美元。看看其他分析師如何看待這隻股票。
Considering buying Citi stock? Here's what analysts think:
考慮購買花旗股票?以下是分析師的想法:
Read This Next:
接下來閱讀這篇文章:
- Honeywell, Salesforce And 3 Stocks To Watch Heading Into Tuesday
- 霍尼韋爾、Salesforce和三隻股票在週二值得關注